"We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but ...

Breakthroughs in age-related macular degeneration (AMD) treatments have revolutionized the management ... While 80% of people with GA experience improvement with these drugs, 20% do not. Both drugs ...

Aging Population and Pipeline Launches Fuel Rapid Growth in Ophthalmic Pharma MarketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmic Drugs Market Report 2025-2035" has been added to ...

Enrollment in DURAVYU Phase 3 wet AMD clinical trials exceeding expectations with the LUGANO trial one-third enrolled and the LUCIA trial ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

Saskatoon safe consumption site Prairie Harm Reduction is warning people of a potentially “bad” batch of drugs in the city. The non-profit organization noticed a spike in suspected overdoses near the ...

a range of medications are available to treat the different physical symptoms that MS can cause. Fatigue is a common symptom for people with MS. Drugs used to treat fatigue include modafinil ...

In its early stages, diabetic retinopathy may not cause noticeable symptoms, but as it progresses, it can lead to blurred ...

But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of falling, which can lead to devastating, even fatal, complications. Falls are ...

a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 in the open-access journal PLOS Biology by Beata ... Age-related macular ...